Teglutik 50mg/10ml, suspension buvable

7680664340013 CH-66434 suspension

Associated product:

TEGLUTIK susp 50 mg/10ml buvable fl 300 ml
Teglutik 50mg/10ml, suspension buvable
Teglutik 50mg/10ml, suspension buvable
Teglutik 50mg/10ml, suspension buvable
1 / 3
google

Article details

Package size
300
Selling units
300
Measure
ml
Galenic form
suspension
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
10/08/2022
Patient information leaflet
Français
10/08/2022
Patient information leaflet
Italien
10/08/2022
Summary of Product Characteristics
Allemand
09/08/2022
Summary of Product Characteristics
Français
09/08/2022
Summary of Product Characteristics
Italien
09/08/2022

Detailed composition

Substance Quantity Type Category
(N/A)
50.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance AIMDK

Reimbursement information

Public price
CHF 127.35
Specialties list
Yes
Generic
No
SL addition date: 01/10/2018

Authorization holder

EFFIK SA

1260 Nyon

Authorization information

Swissmedic authorization number
66434
Drug name
Teglutik, suspension buvable
Galenic form
SUOR
ATC Code
N07XX02
Authorization status
Z
Dispensing category
B
First authorization
26/04/2018
Authorization expiration date
31/12/9999
IT Number
01.99.0.
Domain
Human medicine

Package details

Description (FR)
TEGLUTIK susp 50 mg/10ml buvable fl 300 ml
Description (DE)
TEGLUTIK Susp 50 mg/10ml zum Einnehmen Fl 300 ml
Market launch
26/04/2018
Narcotic (BTM)
No